Cefozopran
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.107.680 |
Chemical and physical data | |
Formula | C19H17N9O5S2 |
Molar mass | 515.52 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Cefozopran (INN) is a fourth-generation cephalosporin.[1]
Spectrum of bacterial susceptibility and resistance
Most of the strains of Stenotrophomonas maltophilia have developed resistance toward cefozopran.[2]
References
- ^ Chang XM (December 1996). "Chapter 34: Market to Market". In Bristol JA (ed.). Annual Reports in Medicinal Chemistry. Vol. 31. San Diego, Calif.: Academic Press. p. 339. ISBN 978-0-08-058375-4.
- ^ "Cefozopran Susceptibility and Resistance Data" (PDF). Retrieved 23 July 2013.
See what we do next...
OR
By submitting your email or phone number, you're giving mschf permission to send you email and/or recurring marketing texts. Data rates may apply. Text stop to cancel, help for help.
Success: You're subscribed now !